Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

08/08/2024 07:04

Aug 8 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             62.57               54.55           261.50    
                 (+14.7 pct)         (+20.2 pct)      (+14.7 pct) 
  Operating          5.67                4.10            19.60    
                 (+38.5 pct)        (+123.1 pct)      (+11.1 pct) 
  Recurring          8.59                6.96            19.20    
                 (+23.5 pct)        (+181.8 pct)      (-21.6 pct) 
  Net                5.50                4.75            12.60    
                 (+15.7 pct)        (+245.8 pct)      (-22.1 pct) 
  EPS            111.64 yen           96.51 yen       255.99 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             30.00 yen        30.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T